Literature DB >> 11811884

Estimated varicella incidence on the basis of a seroprevalence survey.

M P Muñoz1, A Domínguez, L Salleras.   

Abstract

Varicella is a disease caused by varicella-zoster virus. It is transmitted via the respiratory route, is highly communicable and mainly affects young children. An effective vaccine is now available, whose routine use is advised by health authorities in the USA and which can prevent severe disease, although breakthrough infections do occur. In deciding whether or not to include a vaccine in the routine vaccination schedule, knowledge of the morbidity of the disease in question is fundamental. Although reporting of varicella is compulsory in Catalonia, doctors only have to report the weekly number of cases diagnosed, and not their age distribution. Given that recent data on the prevalence of the infection in Catalonia according to age groups is available, it was considered that, using these data, an estimation of age-related incidence could be made. The objective of the present study was to estimate the incidence of varicella in Catalonia on the basis of the available seroprevalence data. A curve was fitted to the observed prevalence and point prevalence estimates for all ages were obtained. The incidence was derived by smoothed prevalence for each of these age groups. Estimated variance of the estimated incidence was obtained by the delta method. Predicted prevalence in the 0-4 years age group was calculated by the smoothed prevalence. The model that best fitted the sample prevalence was the exponential function. The estimated number of varicella cases in this study was 46,419 (95% CI 40,507-52,270). As the population in Catalonia in 1996 was 6,090,040, the previous results give an incidence rate of 762.2 per 100,000 persons/year with their 95% CI (666.1-858.3). The method described may be applied to the study of incidence rates in relation to the prevalence of diseases if we accept that the infection produces permanent immunity; the risk of mortality is the same for infected and non-infected subjects and that the disease incidence and population remain constant in time.

Entities:  

Mesh:

Year:  2001        PMID: 11811884      PMCID: PMC2869776          DOI: 10.1017/s0950268801006264

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  3 in total

Review 1.  A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data.

Authors:  K Bollaerts; M Riera-Montes; U Heininger; N Hens; A Souverain; T Verstraeten; S Hartwig
Journal:  Epidemiol Infect       Date:  2017-08-22       Impact factor: 2.451

2.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

3.  Clinical epidemiology of chickenpox in Iraq from 2007-2011.

Authors:  Hanan Abdulghafoor Khaleel; Hassan Muslem Abdelhussein
Journal:  Glob J Health Sci       Date:  2012-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.